During the COVID-19 pandemic, people with multiple sclerosis (MS) and their healthcare providers have faced unique challenges related to the interaction between SARS-CoV-2, underlying neurological disease and the use of disease- modifying treatments (DMTs). Key concerns arose, primarily related to the possibility that SARS-CoV-2 infection could...
-
2024 (v1)PublicationUploaded on: October 25, 2024
-
October 1, 2021 (v1)Journal article
IMPORTANCE: Younger age, oligoclonal bands, and infratentorial and spinal cord lesions are factors associated with an increased 10-year risk of clinical conversion from radiologically isolated syndrome (RIS) to multiple sclerosis (MS). Whether disease-modifying therapy is beneficial for individuals with RIS is currently unknown. OBJECTIVES: To...
Uploaded on: December 3, 2022 -
August 2020 (v1)Journal article
We have previously identified male sex, younger age, and the presence of spinal cord lesions as independent factors that increase the 5-year risk for evolution from radiologically isolated syndrome (RIS) to multiple sclerosis. Here, we investigate risk factors for the development of a clinical event using a 10-year, multinational,...
Uploaded on: December 3, 2022